United States Opioids Market Report 2016

November 2016 | 102 pages | ID: UA3DBD0B390EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Opioids

Revenue, means the sales value of Opioids

This report studies sales (consumption) of Opioids in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Sanofi-aventis
• Johnson & Johnson
• Teva pharmaceuticals
• Purdue Pharma
• Pfizer
• Orexo Pharmaceuticals
• Endo Pharmaceuticals
• AbbVie
• Allergan
• Hospira

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Hydrocodone (e.g., Vicodin)
• Codeine
• Oxycodone (e.g., OxyContin, Percocet)
• Morphine (e.g., Kadian, Avinza)
• Others

Split by applications, this report focuses on sales, market share and growth rate of Opioids in each application, can be divided into

• Neuropathic pain treatment
• Orthopedic pain treatment
• Other pain treatment

Contents

United States Opioids Market Report 2016

1 OPIOIDS OVERVIEW

1.1 Product Overview and Scope of Opioids
1.2 Classification of Opioids
  1.2.1 Hydrocodone (e.g., Vicodin)
  1.2.2 Codeine
  1.2.3 Oxycodone (e.g., OxyContin, Percocet)
  1.2.4 Morphine (e.g., Kadian, Avinza)
  1.2.5 Others
1.3 Application of Opioids
  1.3.1 Neuropathic pain treatment
  1.3.2 Orthopedic pain treatment
  1.3.3 Other pain treatment
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Opioids (2011-2021)
  1.4.1 United States Opioids Sales and Growth Rate (2011-2021)
  1.4.2 United States Opioids Revenue and Growth Rate (2011-2021)

2 UNITED STATES OPIOIDS COMPETITION BY MANUFACTURERS

2.1 United States Opioids Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Opioids Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Opioids Average Price by Manufactures (2015 and 2016)
2.4 Opioids Market Competitive Situation and Trends
  2.4.1 Opioids Market Concentration Rate
  2.4.2 Opioids Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES OPIOIDS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Opioids Sales and Market Share by Type (2011-2016)
3.2 United States Opioids Revenue and Market Share by Type (2011-2016)
3.3 United States Opioids Price by Type (2011-2016)
3.4 United States Opioids Sales Growth Rate by Type (2011-2016)

4 UNITED STATES OPIOIDS SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Opioids Sales and Market Share by Application (2011-2016)
4.2 United States Opioids Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES OPIOIDS MANUFACTURERS PROFILES/ANALYSIS

5.1 Sanofi-aventis
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Opioids Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Sanofi-aventis Opioids Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Johnson & Johnson
  5.2.2 Opioids Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Johnson & Johnson Opioids Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Teva pharmaceuticals
  5.3.2 Opioids Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Teva pharmaceuticals Opioids Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Purdue Pharma
  5.4.2 Opioids Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Purdue Pharma Opioids Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Pfizer
  5.5.2 Opioids Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Pfizer Opioids Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Orexo Pharmaceuticals
  5.6.2 Opioids Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Orexo Pharmaceuticals Opioids Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Endo Pharmaceuticals
  5.7.2 Opioids Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Endo Pharmaceuticals Opioids Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 AbbVie
  5.8.2 Opioids Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 AbbVie Opioids Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Allergan
  5.9.2 Opioids Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Allergan Opioids Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Hospira
  5.10.2 Opioids Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Hospira Opioids Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview

6 OPIOIDS MANUFACTURING COST ANALYSIS

6.1 Opioids Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Opioids

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Opioids Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Opioids Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES OPIOIDS MARKET FORECAST (2016-2021)

10.1 United States Opioids Sales, Revenue Forecast (2016-2021)
10.2 United States Opioids Sales Forecast by Type (2016-2021)
10.3 United States Opioids Sales Forecast by Application (2016-2021)
10.4 Opioids Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Opioids
Table Classification of Opioids
Figure United States Sales Market Share of Opioids by Type in 2015
Figure Hydrocodone (e.g., Vicodin) Picture
Figure Codeine Picture
Figure Oxycodone (e.g., OxyContin, Percocet) Picture
Figure Morphine (e.g., Kadian, Avinza) Picture
Figure Others Picture
Table Application of Opioids
Figure United States Sales Market Share of Opioids by Application in 2015
Figure Neuropathic pain treatment Examples
Figure Orthopedic pain treatment Examples
Figure Other pain treatment Examples
Figure United States Opioids Sales and Growth Rate (2011-2021)
Figure United States Opioids Revenue and Growth Rate (2011-2021)
Table United States Opioids Sales of Key Manufacturers (2015 and 2016)
Table United States Opioids Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Opioids Sales Share by Manufacturers
Figure 2016 Opioids Sales Share by Manufacturers
Table United States Opioids Revenue by Manufacturers (2015 and 2016)
Table United States Opioids Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Opioids Revenue Share by Manufacturers
Table 2016 United States Opioids Revenue Share by Manufacturers
Table United States Market Opioids Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Opioids Average Price of Key Manufacturers in 2015
Figure Opioids Market Share of Top 3 Manufacturers
Figure Opioids Market Share of Top 5 Manufacturers
Table United States Opioids Sales by Type (2011-2016)
Table United States Opioids Sales Share by Type (2011-2016)
Figure United States Opioids Sales Market Share by Type in 2015
Table United States Opioids Revenue and Market Share by Type (2011-2016)
Table United States Opioids Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Opioids by Type (2011-2016)
Table United States Opioids Price by Type (2011-2016)
Figure United States Opioids Sales Growth Rate by Type (2011-2016)
Table United States Opioids Sales by Application (2011-2016)
Table United States Opioids Sales Market Share by Application (2011-2016)
Figure United States Opioids Sales Market Share by Application in 2015
Table United States Opioids Sales Growth Rate by Application (2011-2016)
Figure United States Opioids Sales Growth Rate by Application (2011-2016)
Table Sanofi-aventis Basic Information List
Table Sanofi-aventis Opioids Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi-aventis Opioids Sales Market Share (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Opioids Sales, Revenue, Price and Gross Margin (2011-2016)
Table Johnson & Johnson Opioids Sales Market Share (2011-2016)
Table Teva pharmaceuticals Basic Information List
Table Teva pharmaceuticals Opioids Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva pharmaceuticals Opioids Sales Market Share (2011-2016)
Table Purdue Pharma Basic Information List
Table Purdue Pharma Opioids Sales, Revenue, Price and Gross Margin (2011-2016)
Table Purdue Pharma Opioids Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Opioids Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Opioids Sales Market Share (2011-2016)
Table Orexo Pharmaceuticals Basic Information List
Table Orexo Pharmaceuticals Opioids Sales, Revenue, Price and Gross Margin (2011-2016)
Table Orexo Pharmaceuticals Opioids Sales Market Share (2011-2016)
Table Endo Pharmaceuticals Basic Information List
Table Endo Pharmaceuticals Opioids Sales, Revenue, Price and Gross Margin (2011-2016)
Table Endo Pharmaceuticals Opioids Sales Market Share (2011-2016)
Table AbbVie Basic Information List
Table AbbVie Opioids Sales, Revenue, Price and Gross Margin (2011-2016)
Table AbbVie Opioids Sales Market Share (2011-2016)
Table Allergan Basic Information List
Table Allergan Opioids Sales, Revenue, Price and Gross Margin (2011-2016)
Table Allergan Opioids Sales Market Share (2011-2016)
Table Hospira Basic Information List
Table Hospira Opioids Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hospira Opioids Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Opioids
Figure Manufacturing Process Analysis of Opioids
Figure Opioids Industrial Chain Analysis
Table Raw Materials Sources of Opioids Major Manufacturers in 2015
Table Major Buyers of Opioids
Table Distributors/Traders List
Figure United States Opioids Production and Growth Rate Forecast (2016-2021)
Figure United States Opioids Revenue and Growth Rate Forecast (2016-2021)
Table United States Opioids Production Forecast by Type (2016-2021)
Table United States Opioids Consumption Forecast by Application (2016-2021)